Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Atorvastatin for Dry Eye with MGD
NCT06208384Phase 2Active, not recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin 1.2% gel in dry eye disease (DED), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2024; status: active, not recruiting.
02
Drugs
atorvastatin 1.2% gel
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06208384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208384.